Cresco Labs Inc

Company Profile

Cresco Labs Inc had its IPO on under the ticker symbol CRLBF.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Cresco Labs Inc has a staff strength of 3,200 employees.

Stock update

Shares of Cresco Labs Inc opened at $2.74 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $2.23 - $2.74, and closed at $2.37.

This is a -11.57% slip from the previous day's closing price.

A total volume of 2,132,853 shares were traded at the close of the day’s session.

In the last one week, shares of Cresco Labs Inc have increased by +42.77%.

Cresco Labs Inc's Key Ratios

Cresco Labs Inc has a market cap of $509.25 million, indicating a price to book ratio of 0.946 and a price to sales ratio of 0.8311.

In the last 12-months Cresco Labs Inc’s revenue was $805.94 million with a gross profit of $407.92 million and an EBITDA of $101.35 million. The EBITDA ratio measures Cresco Labs Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Cresco Labs Inc’s operating margin was 5.88% while its return on assets stood at 1.78% with a return of equity of -33.05%.

In Q1, Cresco Labs Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 9.1%.

Cresco Labs Inc’s PE and PEG Ratio

Forward PE

113.6364

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.66 per share while it has a forward price to earnings multiple of 113.6364 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Cresco Labs Inc’s profitability.

Cresco Labs Inc stock is trading at a EV to sales ratio of 1.4995 and a EV to EBITDA ratio of 8.5275. Its price to sales ratio in the trailing 12-months stood at 0.8311.

Cresco Labs Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$1.55 billion

Total Liabilities

$272.55 million

Operating Cash Flow

$0

Capital Expenditure

$0

Dividend Payout Ratio

0%

Cresco Labs Inc ended 2024 with $1.55 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $1.55 billion while shareholder equity stood at $606.73 million.

Cresco Labs Inc ended 2024 with $0 in deferred long-term liabilities, $272.55 million in other current liabilities, in common stock, $0 in retained earnings and $330.56 million in goodwill. Its cash balance stood at $90.45 million and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.

Cresco Labs Inc’s total current assets stands at $286.32 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $0 and inventory worth $0.

In 2024, Cresco Labs Inc's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Cresco Labs Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$2.37

52-Week High

$4.45

52-Week Low

$1.3

Analyst Target Price

$

Cresco Labs Inc stock is currently trading at $2.37 per share. It touched a 52-week high of $4.45 and a 52-week low of $4.45. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $1.57 and 200-day moving average was $1.79 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 2286.4% of the company’s stock are held by insiders while 727.9% are held by institutions.